Increased levels of fibroblast growth factor-like activity in urine from patients with bladder or kidney cancer - PubMed (original) (raw)
. 1988 Apr 15;48(8):2083-8.
Affiliations
- PMID: 3349479
Increased levels of fibroblast growth factor-like activity in urine from patients with bladder or kidney cancer
G W Chodak et al. Cancer Res. 1988.
Abstract
Growth factor activity was partially purified from human renal tumors and a human bladder cancer cell line by heparin-Sepharose chromatography. This activity stimulated bovine capillary endothelial cell proliferation and DNA synthesis in BALB/c 3T3 cells. Partially purified growth factor preparations from these tumors contained a protein with an approximate molecular weight of 17,000 which was recognized by a polyclonal antiserum raised against a peptide fragment of basic fibroblast growth factor (FGF). This growth factor activity appears to be related to basic fibroblast growth factor. Measurement of FGF-like activity in 50 urine samples from 32 adult males showed that 55% (6 of 11) of the urine samples from patients with bladder cancer and 100% (7 of 7) of the urine samples from patients with kidney cancer contained activity equivalent to more than 20 ng of basic FGF/h of urine production. In contrast, only 6% (2 of 32) of the urine samples from controls, patients with a benign disease, or patients with a history of bladder or kidney cancer contained this level of growth factor activity. These results suggest that patients with bladder or kidney cancer release an FGF-like factor into urine which may be used as a marker for these tumors.
Similar articles
- Presence of heparin binding growth factor in mouse bladder tumors and urine from mice with bladder cancer.
Chodak GW, Shing Y, Borge M, Judge SM, Klagsbrun M. Chodak GW, et al. Cancer Res. 1986 Nov;46(11):5507-10. Cancer Res. 1986. PMID: 3756899 - Keratinocyte growth factor and fibroblast growth factor action on DNA synthesis in rat and human hepatocytes: modulation by heparin.
Strain AJ, McGuinness G, Rubin JS, Aaronson SA. Strain AJ, et al. Exp Cell Res. 1994 Feb;210(2):253-9. doi: 10.1006/excr.1994.1037. Exp Cell Res. 1994. PMID: 7507851 - A panel of angiogenic factors for early bladder cancer detection: enzyme immunoassay and Western blot.
Eissa S, Swellam M, Labib RA, El-Zayat T, El Ahmady O. Eissa S, et al. J Urol. 2009 Mar;181(3):1353-60. doi: 10.1016/j.juro.2008.10.102. Epub 2009 Jan 29. J Urol. 2009. PMID: 19185322 - Fibroblast growth factors and their receptors in transitional cell carcinoma.
Munro NP, Knowles MA. Munro NP, et al. J Urol. 2003 Feb;169(2):675-82. doi: 10.1097/01.ju.0000042721.63319.1d. J Urol. 2003. PMID: 12544341 Review. - [Basic fibroblast growth factor in urine].
Ishiwata T, Asano G. Ishiwata T, et al. Nihon Rinsho. 1999 Dec;57 Suppl:589-92. Nihon Rinsho. 1999. PMID: 10778199 Review. Japanese. No abstract available.
Cited by
- Cardiovascular Effects of Renal Distal Tubule Deletion of the FGF Receptor 1 Gene.
Han X, Ross J, Kolumam G, Pi M, Sonoda J, King G, Quarles LD. Han X, et al. J Am Soc Nephrol. 2018 Jan;29(1):69-80. doi: 10.1681/ASN.2017040412. Epub 2017 Oct 9. J Am Soc Nephrol. 2018. PMID: 28993502 Free PMC article. - A place for precision medicine in bladder cancer: targeting the FGFRs.
di Martino E, Tomlinson DC, Williams SV, Knowles MA. di Martino E, et al. Future Oncol. 2016 Oct;12(19):2243-63. doi: 10.2217/fon-2016-0042. Epub 2016 Jul 6. Future Oncol. 2016. PMID: 27381494 Free PMC article. Review. - RANTES and fibroblast growth factor 2 in jawbone cavitations: triggers for systemic disease?
Lechner J, von Baehr V. Lechner J, et al. Int J Gen Med. 2013 Apr 22;6:277-90. doi: 10.2147/IJGM.S43852. Print 2013. Int J Gen Med. 2013. PMID: 23637551 Free PMC article. - Bladder cancer: a simple model becomes complex.
Di Pierro GB, Gulia C, Cristini C, Fraietta G, Marini L, Grande P, Gentile V, Piergentili R. Di Pierro GB, et al. Curr Genomics. 2012 Aug;13(5):395-415. doi: 10.2174/138920212801619232. Curr Genomics. 2012. PMID: 23372425 Free PMC article. - Altered splicing of FGFR1 is associated with high tumor grade and stage and leads to increased sensitivity to FGF1 in bladder cancer.
Tomlinson DC, Knowles MA. Tomlinson DC, et al. Am J Pathol. 2010 Nov;177(5):2379-86. doi: 10.2353/ajpath.2010.100354. Epub 2010 Oct 1. Am J Pathol. 2010. PMID: 20889570 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical